Sri Krishna Pharmaceuticals

Sri Krishna Pharmaceuticals Limited (SKPL), established in 1974, pioneering the manufacture of ACETAMINOPHEN (PARACETAMOL) for the domestic market, is today a renowned and leading supplier of 150+ niche drugs for marquee global customers. Trusted by customers worldwide, we are today, the only organisation in the world to have a USFDA certified facility for the manufacturing of Folic Acid - a product par excellence. To meet the growing demands of our product(s) and solution(s), we have set-up five manufacturing facilities, with multiple chemistry capabilities on different complex organic reactions. These facilities are equipped with classified clean rooms of ISO 8 class (Class 100, 000) for processing of the final critical steps of the drug substances. All our facilities comply with current and the ever demanding GMP standards and have consistently gained several regulatory certifications including US FDA, EDQM, COFEPRIS, ANVISA, GHA, AIFA, ANSM. Values of Transparency, Trust and Commitment, have been our guiding principles since our inception and is now embedded into our DNA. We believe that these values have enabled us to forge and sustain relationships for 40+ years with our partners and customers across geographical boundaries. Ensuring our customers success has been our foremost priority. Towards this endeavour, we have built our capabilities over the last four decades to provide both backward and forward integration for the processes. Today our expertise extends from manufacturing API, Direct Compression (DC) to Premixes. In our quest for excellence and quality, we have dedicated Quality assurance and Quality control personnel, whose charter is to ensure that our resources, practices and processes are continuously audited, reviewed and upgraded. Our sustained market leadership in Acetaminophen (Paracetamol), Folic Acid, Domperidone, Furosemide, Glebenclamide/Glipizide and Acetaminophen (Paracetamol) DC across Asian, European and US markets are a testimony of our capabilities and commitment to quality. All our critical functions are led by qualified and trained professionals, supported by a well-knit quality management system. We believe that to consistently grow and gain market leadership Collaboration, Innovation, Relationship and Ethical businesses practices are non-negotiable. Hence we continue to invest in our people, technology and markets. We are currently focussing our research efforts in the field of biotechnology through global collaborations.